How did Abbott's Medical Devices segment perform in Q4 2024?

Abbott's Medical Devices segment showed strong performance in Q4 2024, with notable growth in key financial metrics:

1. Revenue Growth: The segment experienced a year-over-year revenue growth rate of 7%, reaching a total revenue of $10.24 billion. This indicates a robust market demand and effective market penetration by the company's medical devices.
2. Net Income Growth: Net income within the Medical Devices segment grew by 4.79% year-over-year, amounting to $1.59 billion. This suggests that the segment is not only increasing its revenue but also improving its profitability.
3. Earnings Per Share (EPS) Growth: The Diluted EPS grew by 4.79%, reaching $0.91, which is a positive indicator of the segment's profitability and returns for shareholders.

Overall, Abbott's Medical Devices segment had a solid performance in Q4 2024, marked by healthy revenue and income growth, and strong earnings per share. These positive results reflect the segment's ability to capitalize on market opportunities and manage its operations effectively.